(Q38163049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

David Taylor

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Robert Stewart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Y-P Su

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C-K Chang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Harrison

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

W Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Broadbent

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

15 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

Acta Psychiatrica Scandinavica

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

52-60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

How "malignant" is the neuroleptic malignant syndrome?

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Risk factors in neuroleptic malignant syndrome. A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Meta-analytic evidence of systematic bias in estimates of neuroleptic malignant syndrome incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Neuroleptic malignant syndrome in 12 of 9,792 Chinese inpatients exposed to neuroleptics: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Case-control study of neuroleptic malignant syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Neuroleptic malignant syndrome associated with atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Atypical neuroleptic malignant syndrome caused by olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Risk factors for neuroleptic malignant syndrome. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: the SLAM BRC Case Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Spectrum concept of neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

International consensus study of antipsychotic dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Neuroleptic malignant syndrome: review and analysis of 115 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Aripiprazole and neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Incidence and risk factors in neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

Retrospective chart review of catatonia in child and adolescent psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12222

21 January 2018

Identifiers

DOI

10.1111/ACPS.12222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24237642%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference